A. Jassem

发表

AMINOGLYCOSIDE SUSCEPTIBILITY AND ACQUIRED RESISTANCE IN

A. Jassem, 2012 .

Pooled Nucleic Acid Amplification Test for Screening of Stool Specimens for Shiga Toxin-Producing Escherichia coli

L. Hoang, Matthew A. Croxen, N. Prystajecky, 2016, Journal of Clinical Microbiology.

Clinical Performance of Check-Direct CPE, a Multiplex PCR for Direct Detection of bla KPC, bla NDM and/or bla VIM, and bla OXA-48 from Perirectal Swabs

G. Fahle, J. Dekker, K. Frank, 2015, Journal of Clinical Microbiology.

vietnamiensis to Aminoglycosides Susceptibility of Burkholderia In Vitro

R. Hancock, R. Ernst, D. Speert, 2014 .

In Vitro Susceptibility of Burkholderia vietnamiensis to Aminoglycosides

R. Hancock, R. Ernst, D. Speert, 2011, Antimicrobial Agents and Chemotherapy.

Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens

L. Hoang, J. Tyson, N. Prystajecky, 2021, International Journal of Infectious Diseases.

Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens

L. Hoang, J. Tyson, N. Prystajecky, 2021, International Journal of Infectious Diseases.

Diagnostic Yield of Laboratory Methods and Value of Viral Genotyping during an Outbreak of Mumps in a Partially Vaccinated Population in British Columbia, Canada

M. Naus, M. Krajden, A. Jassem, 2018, Journal of Clinical Microbiology.

FilmArray respiratory panel assay: An effective method for detecting viral and atypical bacterial pathogens in bronchoscopy specimens

A. Stefanović, L. Hoang, E. Bryce, 2019, Diagnostic Microbiology and Infectious Disease.

Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017

D. Skowronski, N. Bastien, R. Balshaw, 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

The Contrasting Role of Nasopharyngeal Angiotensin Converting Enzyme 2 (ACE2) Expression in SARS-CoV-2 Infection: A Cross-Sectional Study of People Tested for COVID-19 in British Columbia

C. Steidl, H. Sbihi, N. Prystajecky, 2020, medRxiv.

Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity

B. Grunau, Martin A. Prusinkiewicz, P. Lavoie, 2022, bioRxiv.

Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada

C. Fjell, H. Sbihi, N. Prystajecky, 2022, Frontiers in Public Health.

Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness?

D. Skowronski, K. Fonseca, M. Petric, 2018, Open forum infectious diseases.

TARGETED RESEQUENCING OF WETLAND SEDIMENT AS A TOOL FOR AVIAN INFLUENZA VIRUS SURVEILLANCE

N. Prystajecky, P. Tang, M. Coombe, 2019, The Journal of Wildlife Diseases.

Development and validation of a real-time, reverse transcription PCR assay for rapid and low-cost genotyping of hepatitis C virus genotypes 1a, 1b, 2, and 3a.

Andrea D. Olmstead, M. Krajden, Tracy D. Lee, 2017, Journal of virological methods.

Measles Lymphadenopathy in a Child With PFAPA Syndrome

K. Brown, L. Tucker, M. Krajden, 2018, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada

D. Skowronski, N. Zelyas, G. De Serres, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination in British Columbia, Canada: a Prospective Cohort Study

M. Morshed, I. Sekirov, D. Goldfarb, 2022, medRxiv.

Characterization of Clostridium difficile Strains in British Columbia, Canada: A Shift from NAP1 Majority (2008) to Novel Strain Types (2013) in One Region

L. Hoang, M. Mulvey, B. Gamage, 2016, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Escherichia albertii and Hafnia alvei are candidate enteric pathogens with divergent effects on intercellular tight junctions.

P. Sherman, N. Jandu, K. Donato, 2008, Microbial pathogenesis.

HIV serology signal-to-cutoff ratio as a rapid method to predict confirmation of HIV infection

L. Merrick, C. Lowe, D. Puddicombe, 2018, European Journal of Clinical Microbiology & Infectious Diseases.

Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018

D. Skowronski, N. Bastien, G. De Serres, 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010–2011 to 2016–2017

D. Skowronski, G. De Serres, C. Chambers, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018

D. Skowronski, K. Fonseca, N. Bastien, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Investigation of aminoglycoside resistance inducing conditions and a putative AmrAB-OprM efflux system in Burkholderia vietnamiensis

D. Speert, A. Jassem, C. Forbes, 2014, Annals of Clinical Microbiology and Antimicrobials.

Influence of chronic hepatitis C infection on the monocyte-to-platelet ratio: data analysis from the National Health and Nutrition Examination Survey (2009–2016)

M. E. Karim, D. Patrick, A. Jassem, 2021, BMC Public Health.

Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008–2019

N. Janjua, P. Adu, E. Yoshida, 2020, PloS one.

A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2

D. Esposito, D. Douek, M. Görges, 2021, JCI insight.

Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort Study

N. Prystajecky, M. Morshed, I. Sekirov, 2022, Viruses.

Optimization of magnetic bead-based nucleic acid extraction for SARS-CoV-2 testing using readily available reagents

A. Manges, M. Krzywinski, M. Marra, 2021, Journal of Virological Methods.

Evaluation of the clinical and analytical performance of the Seegene allplex™ SARS-CoV-2 variants I assay for the detection of variants of concern (VOC) and variants of interests (VOI)

N. Prystajecky, M. Caza, C. Hogan, 2021, Journal of Clinical Virology.

Extraction and Detection of Avian Influenza Virus From Wetland Sediment Using Enrichment-Based Targeted Resequencing

N. Prystajecky, Miguel I. Uyaguari-Díaz, P. Tang, 2020, Frontiers in Veterinary Science.

Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January–April 2021

C. Fjell, L. Hoang, H. Sbihi, 2021, Emerging infectious diseases.

Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals

M. Petric, B. Grunau, P. Levett, 2022, Microbiology spectrum.

Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada

C. Fjell, D. Skowronski, L. Hoang, 2021, medRxiv.

Mapping SARS-CoV-2 antigenic relationships and serological responses

X. Daniell, R. Webby, M. Stockwell, 2022, bioRxiv.

The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada

C. Steidl, H. Sbihi, N. Prystajecky, 2021, EBioMedicine.

Population SARS-CoV-2 Seroprevalence Using Antenatal Serum Samples in British Columbia, Canada

C. Elwood, H. Sbihi, E. McClymont, 2021, Journal of Obstetrics and Gynaecology Canada.

A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval

P. Demers, M. E. Karim, S. Cheskes, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Relationship Between Anti-Spike SARS-CoV-2 Antibody Levels and Risk of Breakthrough COVID-19 Among Fully Vaccinated Adults

B. Grunau, S. O’Brien, S. Drews, 2022, The Journal of infectious diseases.

Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV)

D. Skowronski, N. Bastien, Matthew A. Croxen, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG

N. Prystajecky, M. Morshed, I. Sekirov, 2021, Journal of Clinical Virology.

Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada

D. Skowronski, L. Hoang, H. Sbihi, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016–2017 and 2017–2018 Epidemics in Canada

D. Skowronski, N. Bastien, G. De Serres, 2020, The Journal of infectious diseases.

COVID-19 in an Immunocompromised Host: Persistent Shedding of Viable SARS-CoV-2 and Emergence of Multiple Mutations, a Case Report.

N. Prystajecky, Y. Mirzanejad, G. Deans, 2021, International Journal of Infectious Diseases.

Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273

B. Grunau, S. O’Brien, Martin A. Prusinkiewicz, 2022, Microbiology spectrum.

Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?

M. E. Karim, F. Scheuermeyer, B. Grunau, 2022, Frontiers in Immunology.

Comparative single-dose mRNA and ChAdOx1 vaccine effectiveness against SARS-CoV-2, including early variants of concern: a test-negative design, British Columbia, Canada

C. Fjell, D. Skowronski, L. Hoang, 2021, medRxiv.

Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ‎possible cohort effect following the 2009 influenza pandemic

D. Skowronski, N. Bastien, Matthew A. Croxen, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020

D. Skowronski, N. Bastien, Matthew A. Croxen, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Influenza Classification Suite: An automated Galaxy workflow for rapid influenza sequence analysis

Mel Krajden, D. Skowronski, William W. L. Hsiao, 2020, Influenza and other respiratory viruses.

Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23

D. Skowronski, N. Bastien, N. Zelyas, 2023, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Comprehensive Immune Profiling of a Kidney Transplant Recipient With Peri-Operative SARS-CoV-2 Infection: A Case Report

P. Keown, M. Morshed, I. Sekirov, 2021, Frontiers in Immunology.

Investigation of aminoglycoside resistance inducing conditions and a putative AmrAB-OprM efflux system in Burkholderia vietnamiensis

D. Speert, A. Jassem, Connor M. Forbes, 2014, Annals of Clinical Microbiology and Antimicrobials.

Evaluation of the Performance of a Multiplexed Serological Assay in the Detection of SARS-CoV-2 Infections in a Predominantly Vaccinated Population

P. Demers, M. E. Karim, T. Kirkham, 2022, Microbiology spectrum.

Simple approximation of sample size for precise estimates of SARS-CoV-2 infection from point-seroprevalence studies

I. Sekirov, A. Jassem, A. Nikiforuk, 2022, Public Health.

Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks

M. Morshed, I. Sekirov, M. Krajden, 2022, Frontiers in Immunology.

Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including P.1 and B.1.1.7 variants: a test-negative design in adults 70 years and older in British Columbia, Canada

D. Skowronski, L. Hoang, H. Sbihi, 2021, medRxiv.

Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response

M. Sadarangani, G. Sinclair, M. Morshed, 2022, Microbiology spectrum.

Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Measure SARS-CoV-2 Humoral Immunogenicity

M. Sadarangani, G. Sinclair, M. Morshed, 2021, medRxiv.

Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada

D. Skowronski, M. Morshed, I. Sekirov, 2022, Frontiers in Immunology.

Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018

D. Skowronski, K. Fonseca, N. Bastien, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

C. Fjell, D. Skowronski, M. Brisson, 2022 .

Identification of synergists that potentiate the action of polymyxin B against Burkholderia cenocepacia.

J. Davies, M. Valvano, D. Speert, 2015, International journal of antimicrobial agents.

Escherichia albertii and Hafnia alvei are candidate enteric pathogens with divergent effects on intercellular tight junctions.

P. Sherman, N. Jandu, A. Jassem, 2008, Microbial pathogenesis.

Antibody reactivity to SARS-CoV-2 is common in unexposed adults and infants under 6 months

D. Douek, A. McDermott, S. Narpala, 2020 .

Nasopharyngeal angiotensin converting enzyme 2 (ACE2) expression as a risk-factor for SARS-CoV-2 transmission in concurrent hospital associated outbreaks

I. Sekirov, A. Jassem, K. Kuchinski, 2023, medRxiv.

Prospective, clinical comparison of self-collected throat-bilateral nares swabs and saline gargle compared to health care provider collected nasopharyngeal swabs among symptomatic outpatients with potential SARS-CoV-2 infection.

N. Prystajecky, A. Jassem, Ron Chow, 2024, Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada.